Market revenue for microfluidics in North America is expected to grow steadily over the forecast period. Starting at $1,450 Million in 2020, the market is projected to reach nearly $3,250 Million in 2025, spurred by innovation in diagnostics and drug development. By 2030, revenue is anticipated to surpass $5,000 Million, with further expansion likely to $8,200 Million by 2035 as new applications emerge across healthcare, environmental, and industrial sectors. Key contributors include increased funding for R&D and rapid technological integration.
Read More - https://bussinessinsights.com/research-report/north-america-microfluidics-market
In-vitro diagnostics holds the largest share of the North America Microfluidics Market by application segment, accounting for the bulk of installed systems and revenue. Pharmaceutical & Life Science Research follows closely, driven by rising adoption for drug discovery, personalized medicine, and preclinical trials. Point of Care Testing demonstrates robust growth as healthcare shifts to decentralized, rapid testing settings. Environmental & Industrial, Drug Delivery, and 'Others' continue to gain ground as awareness rises in non-traditional sectors.
Request Free Sample- https://bussinessinsights.com/request/healthcare/north-america-microfluidics-market
Who are the key players in North America Microfluidics Market industry?
The top 5 players in the North America Microfluidics Market are Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, and Fluidigm Corporation. These companies lead through technological innovations, broad product portfolios, strategic acquisitions, and strong distribution networks supporting research, diagnostics, and point-of-care applications.
What is the North America Microfluidics Market growth?
The North America Microfluidics Market is experiencing steady growth, driven by rising demand for point-of-care diagnostics, drug development, and genomics. For example, Thermo Fisher Scientific reported a significant increase in its microfluidics-based product sales in 2023, fueled by advanced healthcare and diagnostic applications.
Which segment accounted for the largest North America Microfluidics Market share?
In 2023, the diagnostics segment accounted for the largest share of the North America Microfluidics Market. The wide adoption of microfluidic technologies in point-of-care and laboratory diagnostics, aided by rapid, cost-effective, and sensitive analysis provided by companies like Bio-Rad Laboratories, has driven the segment's dominance.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com